Log In
BCIQ
Print this Print this
 

Plenaxis, abarelix

Also known as: Abarelix Depot-F, Abarelix Depot-M (PPI-149)

  Manage Alerts
Collapse Summary General Information
Company Speciality European Pharma Ltd.
DescriptionLuteinizing hormone-releasing hormone (LHRH)/gonadotropin-releasing hormone (GnRH) antagonist
Molecular Target GnRH/LHRH receptor
Mechanism of ActionGnRH/LHRH receptor antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationProstate cancer
Indication DetailsTreat advanced or metastatic hormone-dependent prostate cancer in cases where androgen suppression is appropriate; Treat advanced prostate cancer patients for whom hormone therapies may not be appropriate; Treat hormone-responsive prostate cancer; Treat patients with advanced symptomatic prostate cancer; Treat prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today